Shape-directed drug release and transport of erythrocyte-like nanodisks augment chemotherapy

J Control Release. 2022 Oct:350:886-897. doi: 10.1016/j.jconrel.2022.09.005. Epub 2022 Sep 15.

Abstract

Nanoparticle shape has been recognized as a crucial parameter to affect the transport across various biological barriers, but its impact on drug release and the resulting therapeutic efficacy is less understood. Inspired by erythrocytes with shape-facilitated oxygen-carrying and penetrating abilities, we constructed artificial erythrocyte-like nanoparticles (RNDs) by wrapping discoidal mesoporous silica nanoparticles with red blood cell membrane. We observed that, compared with their spherical and rod-shaped counterparts with monotonic drug release profiles, RNDs displayed an on-demand drug release pattern mimicking natural erythrocytes, that is, they could rapidly release loaded oxygen and doxorubicin (DOX) in hypoxic condition but were relatively stable in high oxygen areas. Besides, the discoidal shape also endowed RNDs with facilitated transport capability in tumor extracellular matrix, contributing to increased tumor permeability. In tumor models, systemically administrated RNDs efficiently infiltrate throughout tumor tissue, successfully relieve tumor hypoxia, and further altered the cancer cell cycle status from G1 to G2 phase, enhancing cancer cell sensitivity to DOX correlated with improved chemotherapy efficacy. In contrast, nanospheres show hampered permeability, and nanorods suffer from insufficient intratumoral drug accumulation. These findings can offer guidelines for the use of particle shape as a design criterion to control drug release, transportation, and therapeutics delivery.

Keywords: Biological barriers; Drug release; Erythrocyte-like nanoparticles; Shape effect; Tumor penetration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Substitutes* / therapeutic use
  • Cell Line, Tumor
  • Doxorubicin
  • Drug Carriers
  • Drug Delivery Systems / methods
  • Drug Liberation
  • Erythrocyte Membrane
  • Humans
  • Nanoparticles* / therapeutic use
  • Nanospheres*
  • Neoplasms* / drug therapy
  • Oxygen
  • Silicon Dioxide

Substances

  • Blood Substitutes
  • Drug Carriers
  • Silicon Dioxide
  • Doxorubicin
  • Oxygen